Androgen [EPC]

Androgen [EPC] was reported 27346 times

Drugs of the Androgen [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PERFORMANCE ENHANCING PRODUCT USE 27 0.2727
1 VIRILISM 25 0.2273
2 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 87 0.1895
3 POLYCYTHAEMIA 302 0.1462
4 CERVIX CARCINOMA STAGE IV 20 0.1379
5 SECONDARY HYPOGONADISM 43 0.1303
6 TOXIC CARDIOMYOPATHY 29 0.1295
7 ACNE FULMINANS 24 0.1224
8 BLOOD TESTOSTERONE INCREASED 241 0.1120
9 ENLARGED CLITORIS 18 0.1091
10 EXPULSION OF MEDICATION 57 0.1078
11 PRODUCT DEPOSIT 147 0.0943
12 PRECOCIOUS PUBERTY 52 0.0911
13 HEPATIC ADENOMA 43 0.0832
14 RENAL ARTERY THROMBOSIS 24 0.0777
15 CLEAR CELL RENAL CELL CARCINOMA 50 0.0718
16 BREAST HYPERPLASIA 25 0.0710
17 CENTRAL SEROUS CHORIORETINOPATHY 47 0.0688
18 BLOOD TESTOSTERONE DECREASED 458 0.0669
19 OESTRADIOL INCREASED 20 0.0664
20 CRANIOPHARYNGIOMA 21 0.0633
21 IDIOPATHIC INTRACRANIAL HYPERTENSION 121 0.0538
22 BLOOD GROWTH HORMONE INCREASED 28 0.0502
23 TESTICULAR ATROPHY 43 0.0493
24 METAPLASIA 23 0.0487
25 MUSCLE MASS 22 0.0487
26 BLOOD TESTOSTERONE ABNORMAL 53 0.0479
27 MESENTERIC VEIN THROMBOSIS 47 0.0471
28 ENDOMETRIAL ADENOCARCINOMA 28 0.0440
29 BLOOD OESTROGEN INCREASED 25 0.0424
30 BLOOD OESTROGEN DECREASED 28 0.0398
31 INFERTILITY MALE 18 0.0398
32 HYPOGONADISM 40 0.0396
33 RENAL INFARCT 56 0.0387
34 LYMPHADENITIS 90 0.0371
35 POLYCYTHAEMIA VERA 29 0.0354
36 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 52 0.0324
37 CARDIAC VENTRICULAR THROMBOSIS 38 0.0294
38 INSULIN-LIKE GROWTH FACTOR INCREASED 42 0.0294
39 CORONARY ARTERY DISSECTION 25 0.0291
40 PRODUCT DELIVERY MECHANISM ISSUE 155 0.0288
41 HAEMATOCRIT INCREASED 65 0.0285
42 ISCHAEMIA 130 0.0283
43 OBSTRUCTIVE SLEEP APNOEA SYNDROME 40 0.0274
44 MYOCARDIAL FIBROSIS 23 0.0274
45 BRUGADA SYNDROME 25 0.0242
46 HEREDITARY ANGIOEDEMA 241 0.0224
47 CARDIAC DEATH 27 0.0224
48 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 24 0.0218
49 CEREBRAL VENOUS SINUS THROMBOSIS 18 0.0213
50 RECALLED PRODUCT 35 0.0202
51 INFARCTION 137 0.0200
52 PITUITARY TUMOUR BENIGN 32 0.0196
53 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 52 0.0195
54 IMPLANT SITE SWELLING 19 0.0186
55 PRODUCT PHYSICAL CONSISTENCY ISSUE 103 0.0186
56 ECONOMIC PROBLEM 282 0.0186
57 IMPLANT SITE INFECTION 43 0.0185
58 BONE DEMINERALISATION 18 0.0170
59 LEFT VENTRICULAR HYPERTROPHY 72 0.0168
60 LYMPHOPROLIFERATIVE DISORDER 48 0.0163
61 RED BLOOD CELL COUNT INCREASED 44 0.0159
62 PORTAL VEIN THROMBOSIS 50 0.0155
63 ACUTE MYOCARDIAL INFARCTION 448 0.0152
64 HAEMOGLOBIN INCREASED 69 0.0151
65 QUALITY OF LIFE DECREASED 202 0.0150
66 IMPLANT SITE PAIN 66 0.0148
67 INVASIVE DUCTAL BREAST CARCINOMA 40 0.0147
68 CEREBRAL VENOUS THROMBOSIS 26 0.0143
69 HAEMOLYSIS 110 0.0142
70 DEEP VEIN THROMBOSIS 902 0.0139
71 ISCHAEMIC CARDIOMYOPATHY 42 0.0137
72 MYELOFIBROSIS 41 0.0135
73 LIBIDO INCREASED 27 0.0133
74 PRODUCT ODOUR ABNORMAL 139 0.0133
75 ENDOMETRIAL CANCER 29 0.0132
76 HYPERCOAGULATION 24 0.0126
77 SELF-MEDICATION 51 0.0124
78 PHYSICAL DISABILITY 53 0.0120
79 PAPILLOEDEMA 54 0.0119
80 CORONARY ARTERY THROMBOSIS 23 0.0114
81 LIQUID PRODUCT PHYSICAL ISSUE 83 0.0114
82 CEREBROSPINAL FLUID LEAKAGE 21 0.0114
83 THROMBOPHLEBITIS SUPERFICIAL 34 0.0112
84 THROMBOCYTOSIS 41 0.0112
85 CORONARY ARTERY DISEASE 331 0.0109
86 VENTRICULAR HYPERTROPHY 26 0.0104
87 MIGRAINE WITH AURA 28 0.0103
88 ADRENOCORTICAL INSUFFICIENCY ACUTE 20 0.0102
89 PULMONARY INFARCTION 24 0.0101
90 PRESCRIBED OVERDOSE 195 0.0101
91 CARDIOVASCULAR DISORDER 255 0.0100
92 CARDIOMYOPATHY 147 0.0099
93 ANHEDONIA 258 0.0098
94 PRE-EXISTING CONDITION IMPROVED 61 0.0098
95 INTRACRANIAL PRESSURE INCREASED 54 0.0097
96 CUSHINGOID 31 0.0096
97 HAIR GROWTH ABNORMAL 66 0.0095
98 SLEEP APNOEA SYNDROME 176 0.0092
99 SWOLLEN TONGUE 288 0.0092
100 PULMONARY EMBOLISM 876 0.0092
101 LACUNAR INFARCTION 22 0.0092
102 INTRACARDIAC THROMBUS 28 0.0091
103 PRODUCT CONTAMINATION PHYSICAL 23 0.0090
104 ACCIDENTAL EXPOSURE 37 0.0089
105 HEART INJURY 22 0.0088
106 CHOLESTATIC LIVER INJURY 19 0.0085
107 PROSTATOMEGALY 33 0.0084
108 LOSS OF EMPLOYMENT 25 0.0083
109 EMBOLISM VENOUS 25 0.0082
110 HORMONE LEVEL ABNORMAL 40 0.0082
111 BENIGN PROSTATIC HYPERPLASIA 42 0.0081
112 PRIAPISM 28 0.0081
113 CONGESTIVE CARDIOMYOPATHY 33 0.0079
114 TESTICULAR PAIN 25 0.0079
115 MULTIPLE USE OF SINGLE-USE PRODUCT 44 0.0078
116 OPTIC ISCHAEMIC NEUROPATHY 30 0.0077
117 POOR QUALITY PRODUCT ADMINISTERED 80 0.0076
118 ERECTILE DYSFUNCTION 193 0.0075
119 SOCIAL PROBLEM 31 0.0075
120 SUDDEN CARDIAC DEATH 25 0.0073
121 LOSS OF LIBIDO 65 0.0072
122 HIGH DENSITY LIPOPROTEIN DECREASED 24 0.0072
123 FAMILY STRESS 22 0.0071
124 ARTERIOSCLEROSIS CORONARY ARTERY 47 0.0071
125 ANGIOEDEMA 311 0.0070
126 OSTEOPENIA 105 0.0069
127 SNORING 26 0.0069
128 HEPATOCELLULAR CARCINOMA 52 0.0068
129 NEOPLASM RECURRENCE 23 0.0068
130 RENAL CELL CARCINOMA 33 0.0067
131 ANORGASMIA 18 0.0066
132 PLANTAR FASCIITIS 22 0.0066
133 BUNDLE BRANCH BLOCK RIGHT 30 0.0065
134 IMPAIRED WORK ABILITY 139 0.0065
135 VENOUS THROMBOSIS 25 0.0064
136 PERIPHERAL ISCHAEMIA 26 0.0064
137 AORTIC STENOSIS 22 0.0063
138 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 39 0.0063
139 DEVICE DELIVERY SYSTEM ISSUE 168 0.0061
140 PRODUCT CONTAINER ISSUE 52 0.0061
141 MYOCARDIAL INFARCTION 1055 0.0060
142 ACUTE CORONARY SYNDROME 50 0.0060
143 CAROTID ARTERY STENOSIS 21 0.0060
144 LEFT VENTRICULAR DYSFUNCTION 40 0.0060
145 BLOOD THYROID STIMULATING HORMONE DECREASED 27 0.0059
146 PERIPHERAL VASCULAR DISORDER 30 0.0058
147 AUTOIMMUNE THYROIDITIS 22 0.0058
148 AORTIC ANEURYSM 44 0.0058
149 DYSPHONIA 337 0.0058
150 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 39 0.0057
151 SPLENOMEGALY 67 0.0057
152 ATRIAL FLUTTER 45 0.0056
153 PRODUCT ADMINISTRATION INTERRUPTED 44 0.0056
154 WOUND COMPLICATION 19 0.0055
155 LACERATION 52 0.0055
156 LEFT VENTRICULAR FAILURE 19 0.0055
157 THROMBOSIS 440 0.0055
158 PLATELET COUNT ABNORMAL 33 0.0055
159 ANEURYSM 27 0.0054
160 MUSCLE RUPTURE 21 0.0054
161 NEPHROPATHY 50 0.0053
162 SERUM FERRITIN INCREASED 28 0.0053
163 OSTEONECROSIS 174 0.0053
164 DRUG ADMINISTERED AT INAPPROPRIATE SITE 55 0.0052
165 ARTERIOSCLEROSIS 49 0.0052
166 AORTIC VALVE INCOMPETENCE 22 0.0052
167 DYSLIPIDAEMIA 26 0.0051
168 CEREBROVASCULAR ACCIDENT 865 0.0051
169 DRUG ABUSE 425 0.0051
170 APPLICATION SITE RASH 69 0.0050
171 PRODUCT RESIDUE PRESENT 27 0.0050
172 FEAR 134 0.0050
173 EMBOLISM 41 0.0049
174 SWELLING FACE 321 0.0049
175 PROSTATIC SPECIFIC ANTIGEN INCREASED 67 0.0049
176 HYPERLIPIDAEMIA 58 0.0048
177 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 264 0.0048
178 IMMUNE THROMBOCYTOPENIA 22 0.0048
179 NEPHROGENIC ANAEMIA 22 0.0047
180 SKIN PAPILLOMA 19 0.0047
181 MUSCLE FATIGUE 20 0.0047
182 PROSTATIC DISORDER 26 0.0047
183 VISUAL FIELD DEFECT 34 0.0047
184 ECCHYMOSIS 32 0.0047
185 TRANSIENT ISCHAEMIC ATTACK 157 0.0046
186 POOR QUALITY DRUG ADMINISTERED 30 0.0046
187 SKIN LACERATION 50 0.0046
188 CORONARY ARTERY OCCLUSION 63 0.0046
189 PRODUCT PHYSICAL ISSUE 92 0.0046
190 CARDIOMEGALY 56 0.0045
191 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 83 0.0045
192 RECALLED PRODUCT ADMINISTERED 43 0.0045
193 FEELING OF DESPAIR 21 0.0045
194 MULTIPLE INJURIES 28 0.0044
195 SPINAL OSTEOARTHRITIS 39 0.0044
196 CARDIAC FAILURE CONGESTIVE 355 0.0044
197 NERVE INJURY 49 0.0044
198 HORDEOLUM 19 0.0044
199 NOCTURIA 53 0.0044
200 PSYCHIATRIC SYMPTOM 32 0.0043
201 EMOTIONAL DISORDER 132 0.0043
202 APPLICATION SITE IRRITATION 53 0.0043
203 MITRAL VALVE INCOMPETENCE 48 0.0042
204 APLASTIC ANAEMIA 22 0.0042
205 CARDIAC FAILURE ACUTE 28 0.0042
206 FOOD CRAVING 22 0.0042
207 HEPATOMEGALY 41 0.0042
208 AFFECTIVE DISORDER 32 0.0041
209 ENERGY INCREASED 24 0.0041
210 PRODUCT ADMINISTRATION ERROR 82 0.0041
211 ATELECTASIS 39 0.0040
212 MYOCARDITIS 45 0.0039
213 VENTRICULAR FIBRILLATION 43 0.0039
214 FLANK PAIN 36 0.0038
215 BRAIN INJURY 38 0.0038
216 INTERVERTEBRAL DISC DEGENERATION 35 0.0038
217 STREPTOCOCCAL INFECTION 21 0.0038
218 APPLICATION SITE PAIN 83 0.0038
219 PRODUCT SOLUBILITY ABNORMAL 19 0.0038
220 BODY HEIGHT DECREASED 40 0.0037
221 SCOLIOSIS 23 0.0037
222 ANGINA UNSTABLE 24 0.0037
223 PLATELET COUNT INCREASED 48 0.0037
224 PERIORBITAL OEDEMA 19 0.0037
225 DIVERTICULUM 26 0.0037
226 SOMNAMBULISM 24 0.0037
227 ARTHROPOD BITE 27 0.0036
228 ISCHAEMIC STROKE 65 0.0036
229 BRAIN FOG 57 0.0036
230 BLOOD TRIGLYCERIDES INCREASED 64 0.0036
231 LOW DENSITY LIPOPROTEIN INCREASED 28 0.0036
232 THERAPEUTIC PRODUCT EFFECT DECREASED 162 0.0036
233 CONCUSSION 28 0.0036
234 DRUG INTOLERANCE 347 0.0036
235 ANXIETY 1020 0.0036
236 SEXUAL DYSFUNCTION 42 0.0036
237 CORONARY ARTERY STENOSIS 18 0.0036
238 RHABDOMYOLYSIS 149 0.0036
239 RENAL TUBULAR NECROSIS 35 0.0036
240 CONCOMITANT DISEASE AGGRAVATED 22 0.0036
241 DECREASED ACTIVITY 38 0.0035
242 ATRIAL FIBRILLATION 342 0.0035
243 MALIGNANT MELANOMA 47 0.0035
244 GLOMERULAR FILTRATION RATE DECREASED 43 0.0035
245 TEMPERATURE INTOLERANCE 36 0.0035
246 MYELODYSPLASTIC SYNDROME 50 0.0035
247 INCORRECT DOSE ADMINISTERED BY DEVICE 90 0.0034
248 HICCUPS 28 0.0034
249 HYPERCALCAEMIA 42 0.0034
250 SPINAL COMPRESSION FRACTURE 28 0.0034
251 ROTATOR CUFF SYNDROME 43 0.0033
252 CARDIOGENIC SHOCK 48 0.0033
253 END STAGE RENAL DISEASE 61 0.0033
254 ARTERIAL OCCLUSIVE DISEASE 26 0.0033
255 SKIN INFECTION 37 0.0033
256 EXOSTOSIS 30 0.0033
257 POST-TRAUMATIC STRESS DISORDER 22 0.0033
258 BRAIN NEOPLASM 30 0.0033
259 PROCEDURAL COMPLICATION 25 0.0033
260 MYOCARDIAL ISCHAEMIA 37 0.0032
261 GOUT 58 0.0032
262 DECREASED INTEREST 19 0.0032
263 EYE MOVEMENT DISORDER 22 0.0032
264 LIMB INJURY 87 0.0032
265 ANGER 108 0.0032
266 VITAMIN D DEFICIENCY 31 0.0032
267 PETECHIAE 33 0.0032
268 MUSCLE ATROPHY 40 0.0032
269 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
270 NASAL DISCOMFORT 25 0.0032
271 SQUAMOUS CELL CARCINOMA OF SKIN 19 0.0031
272 CHRONIC KIDNEY DISEASE 239 0.0031
273 POLLAKIURIA 131 0.0031
274 GINGIVAL PAIN 25 0.0031
275 OSTEOPOROSIS 129 0.0031
276 MUSCLE STRAIN 27 0.0031
277 AFFECT LABILITY 30 0.0031
278 HAEMOGLOBIN ABNORMAL 20 0.0031
279 SEASONAL ALLERGY 44 0.0031
280 NIGHT SWEATS 100 0.0031
281 FRUSTRATION TOLERANCE DECREASED 25 0.0031
282 GINGIVAL BLEEDING 42 0.0031
283 OBESITY 49 0.0031
284 APPLICATION SITE PRURITUS 69 0.0030
285 BREAST CANCER FEMALE 81 0.0030
286 PRODUCT FORMULATION ISSUE 20 0.0030
287 INFUSION SITE SWELLING 19 0.0030
288 BASAL CELL CARCINOMA 47 0.0030
289 CHROMATURIA 68 0.0030
290 MAJOR DEPRESSION 22 0.0030
291 BONE DENSITY DECREASED 94 0.0030
292 OBSESSIVE-COMPULSIVE DISORDER 24 0.0030
293 PRODUCT SUBSTITUTION ISSUE 172 0.0030
294 BLINDNESS TRANSIENT 22 0.0030
295 NO ADVERSE EVENT 539 0.0030
296 INTERVERTEBRAL DISC PROTRUSION 65 0.0030
297 JOINT INJURY 63 0.0029
298 PRODUCT LABEL ISSUE 20 0.0029
299 POLYURIA 24 0.0029
300 APPLICATION SITE VESICLES 19 0.0029
301 MENISCUS INJURY 18 0.0029
302 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 50 0.0029
303 TENDON RUPTURE 36 0.0029
304 EMOTIONAL DISTRESS 351 0.0029
305 INJURY 203 0.0029
306 LARGE INTESTINE POLYP 20 0.0029
307 WALKING AID USER 19 0.0029
308 POOR QUALITY SLEEP 62 0.0029
309 LEUKOCYTOSIS 52 0.0029
310 NEPHROLITHIASIS 131 0.0029
311 BACK INJURY 31 0.0028
312 BRAIN OEDEMA 36 0.0028
313 HEPATIC ENZYME INCREASED 194 0.0028
314 SKIN MASS 19 0.0028
315 HEART RATE IRREGULAR 64 0.0028
316 APPLICATION SITE ERYTHEMA 74 0.0028
317 MULTIPLE ALLERGIES 22 0.0028
318 ADRENAL INSUFFICIENCY 34 0.0028
319 BONE DISORDER 51 0.0028
320 MOOD SWINGS 89 0.0028
321 BREAST TENDERNESS 21 0.0028
322 MIDDLE INSOMNIA 52 0.0028
323 OSTEOARTHRITIS 118 0.0028
324 RENAL CYST 22 0.0028
325 HEAD INJURY 87 0.0027
326 PANIC ATTACK 100 0.0027
327 INTENTIONAL PRODUCT MISUSE 240 0.0027
328 CYST 34 0.0027
329 NEURALGIA 66 0.0027
330 IMPAIRED GASTRIC EMPTYING 37 0.0027
331 CHOLECYSTECTOMY 31 0.0027
332 APPLICATION SITE REACTION 19 0.0027
333 DRUG EFFECT LESS THAN EXPECTED 40 0.0027
334 CELLULITIS 136 0.0027
335 VITAMIN D DECREASED 23 0.0027
336 MYOPATHY 23 0.0027
337 IRRITABILITY 160 0.0027
338 CEREBRAL INFARCTION 65 0.0027
339 PRODUCT ADHESION ISSUE 95 0.0027
340 THERAPEUTIC RESPONSE UNEXPECTED 119 0.0026
341 ACUTE RESPIRATORY FAILURE 51 0.0026
342 TENDONITIS 41 0.0026
343 CARPAL TUNNEL SYNDROME 37 0.0026
344 BODY TEMPERATURE DECREASED 26 0.0026
345 HEPATIC STEATOSIS 49 0.0026
346 TOOTH FRACTURE 29 0.0026
347 DERMATITIS CONTACT 30 0.0026
348 SCAR 45 0.0026
349 SINUS DISORDER 52 0.0026
350 CHOLELITHIASIS 86 0.0026
351 MUSCULOSKELETAL DISCOMFORT 45 0.0026
352 PARANOIA 45 0.0026
353 INCREASED TENDENCY TO BRUISE 24 0.0026
354 MIGRAINE 248 0.0026
355 MENTAL STATUS CHANGES 72 0.0026
356 HYPERCHOLESTEROLAEMIA 25 0.0026
357 MUSCULOSKELETAL CHEST PAIN 40 0.0026
358 PERSONALITY CHANGE 24 0.0026
359 AMNESIA 168 0.0026
360 BIPOLAR DISORDER 28 0.0026
361 DEPRESSION 586 0.0026
362 PULMONARY THROMBOSIS 28 0.0026
363 HAEMORRHAGIC STROKE 20 0.0026
364 MANIA 42 0.0026
365 SQUAMOUS CELL CARCINOMA 24 0.0025
366 CARDIAC MURMUR 22 0.0025
367 DISTURBANCE IN ATTENTION 137 0.0025
368 SINUS TACHYCARDIA 36 0.0025
369 PRODUCT PACKAGING ISSUE 24 0.0025
370 PLATELET COUNT DECREASED 269 0.0025
371 THINKING ABNORMAL 47 0.0025
372 DRUG-INDUCED LIVER INJURY 79 0.0025
373 TRICUSPID VALVE INCOMPETENCE 20 0.0025
374 MENTAL IMPAIRMENT 61 0.0025
375 SPINAL OPERATION 31 0.0025
376 UNEVALUABLE EVENT 190 0.0025
377 PNEUMONIA BACTERIAL 23 0.0025
378 GROIN PAIN 22 0.0025
379 PULMONARY MASS 37 0.0025
380 ANGINA PECTORIS 71 0.0025
381 PRODUCT USE COMPLAINT 39 0.0025
382 RESTLESS LEGS SYNDROME 45 0.0025
383 PROTEINURIA 47 0.0025
384 HYPERSENSITIVITY 457 0.0025
385 DRUG LEVEL DECREASED 25 0.0025
386 MYOSITIS 22 0.0024
387 RED BLOOD CELL COUNT DECREASED 70 0.0024
388 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 82 0.0024
389 TOOTH INFECTION 32 0.0024
390 LIGAMENT SPRAIN 24 0.0024
391 FEELING DRUNK 18 0.0024
392 MOOD ALTERED 66 0.0024
393 ROAD TRAFFIC ACCIDENT 101 0.0024
394 HYPERSOMNIA 69 0.0024
395 HAEMOGLOBIN DECREASED 247 0.0024
396 DEPRESSED MOOD 127 0.0024
397 GASTRITIS 63 0.0024
398 PRODUCT PRESCRIBING ERROR 57 0.0024
399 WEIGHT FLUCTUATION 25 0.0024
400 HYPERHIDROSIS 307 0.0024
401 RIB FRACTURE 49 0.0024
402 BLOOD PRESSURE INCREASED 363 0.0024
403 FOOT FRACTURE 45 0.0024
404 PRODUCT DISTRIBUTION ISSUE 22 0.0024
405 CONTUSION 228 0.0024
406 GYNAECOMASTIA 73 0.0024
407 INSURANCE ISSUE 36 0.0024
408 TINNITUS 108 0.0023
409 DENTAL CARIES 26 0.0023
410 INSOMNIA 626 0.0023
411 FOOT DEFORMITY 26 0.0023
412 EAR DISCOMFORT 24 0.0023
413 GASTROOESOPHAGEAL REFLUX DISEASE 188 0.0023
414 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
415 HYPERTENSION 494 0.0023
416 APATHY 34 0.0023
417 PANCREATITIS 123 0.0023
418 SUICIDAL IDEATION 213 0.0023
419 PRODUCT QUALITY ISSUE 316 0.0023
420 ANKLE FRACTURE 36 0.0023
421 TOOTHACHE 42 0.0023
422 CHEST PAIN 429 0.0023
423 THERAPEUTIC RESPONSE DECREASED 140 0.0023
424 FEELING JITTERY 44 0.0023
425 EYE INFECTION 26 0.0023
426 AGGRESSION 115 0.0023
427 ELECTROCARDIOGRAM ABNORMAL 18 0.0023
428 PAIN 1407 0.0023
429 IMPAIRED DRIVING ABILITY 26 0.0023
430 ASTHENIA 860 0.0023
431 BLOOD GLUCOSE FLUCTUATION 25 0.0023
432 PALLOR 62 0.0023
433 MICTURITION URGENCY 26 0.0023
434 HOT FLUSH 171 0.0023
435 BLOOD CREATININE INCREASED 148 0.0023
436 TOOTH ABSCESS 23 0.0023
437 INFUSION SITE ERYTHEMA 19 0.0023
438 CARDIAC ARREST 185 0.0022
439 SLEEP DISORDER 158 0.0022
440 JOINT RANGE OF MOTION DECREASED 30 0.0022
441 NECK PAIN 125 0.0022
442 UPPER RESPIRATORY TRACT INFECTION 103 0.0022
443 NEPHROPATHY TOXIC 25 0.0022
444 BACK DISORDER 36 0.0022
445 EATING DISORDER 47 0.0022
446 ACUTE HEPATIC FAILURE 30 0.0022
447 ABSCESS 35 0.0022
448 DEVICE DEFECTIVE 38 0.0022
449 RENAL IMPAIRMENT 184 0.0022
450 PERIPHERAL COLDNESS 30 0.0022
451 CHOLECYSTITIS 26 0.0022
452 BLOOD COUNT ABNORMAL 33 0.0022
453 INFUSION RELATED REACTION 144 0.0022
454 INTENTIONAL PRODUCT USE ISSUE 190 0.0022
455 NERVE COMPRESSION 20 0.0022
456 BLOOD PRESSURE SYSTOLIC INCREASED 42 0.0022
457 LOCALISED INFECTION 52 0.0021
458 ACUTE KIDNEY INJURY 329 0.0021
459 OEDEMA PERIPHERAL 262 0.0021
460 INITIAL INSOMNIA 22 0.0021
461 BURSITIS 26 0.0021
462 HYPERTHYROIDISM 31 0.0021
463 BEDRIDDEN 28 0.0021
464 HYPERBILIRUBINAEMIA 22 0.0021
465 PULMONARY CONGESTION 28 0.0021
466 RENAL FAILURE 282 0.0021
467 GASTROINTESTINAL INFECTION 19 0.0021
468 PAIN IN JAW 60 0.0021
469 HAEMATOCRIT DECREASED 42 0.0021
470 OFF LABEL USE 1851 0.0021
471 SMALL INTESTINAL OBSTRUCTION 26 0.0021
472 BLOOD IRON DECREASED 25 0.0021
473 CARDIAC DISORDER 196 0.0021
474 STAPHYLOCOCCAL INFECTION 69 0.0021
475 BLOOD UREA INCREASED 35 0.0021
476 LACRIMATION INCREASED 63 0.0021
477 BACK PAIN 484 0.0021
478 BALANCE DISORDER 180 0.0021
479 THYROID DISORDER 32 0.0021
480 MASS 29 0.0021
481 NODULE 27 0.0021
482 LETHARGY 119 0.0021
483 FEELING ABNORMAL 495 0.0021
484 POST PROCEDURAL HAEMORRHAGE 24 0.0021
485 BLOOD CHOLESTEROL INCREASED 96 0.0021
486 PHOTOSENSITIVITY REACTION 34 0.0021
487 PRESYNCOPE 50 0.0021
488 DRUG ADMINISTRATION ERROR 63 0.0021
489 FLUSHING 208 0.0020
490 HAEMATOMA 53 0.0020
491 BLOOD CALCIUM DECREASED 23 0.0020
492 SKIN LESION 56 0.0020
493 SINUSITIS 209 0.0020
494 MUSCLE TWITCHING 47 0.0020
495 DECREASED IMMUNE RESPONSIVENESS 20 0.0020
496 LUNG INFILTRATION 18 0.0020
497 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18 0.0020
498 HEADACHE 1274 0.0020
499 NEEDLE ISSUE 59 0.0020
500 HIP ARTHROPLASTY 31 0.0020
501 PRODUCT STORAGE ERROR 177 0.0020
502 PRODUCT AVAILABILITY ISSUE 46 0.0020
503 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 97 0.0020
504 INFUSION SITE PAIN 26 0.0020
505 MYALGIA 343 0.0020
506 PULMONARY HYPERTENSION 42 0.0020
507 BONE PAIN 118 0.0020
508 DEVICE RELATED INFECTION 31 0.0020
509 PARAESTHESIA ORAL 29 0.0020
510 IMPAIRED HEALING 66 0.0020
511 COORDINATION ABNORMAL 28 0.0020
512 WHITE BLOOD CELL COUNT INCREASED 77 0.0020
513 HYPONATRAEMIA 113 0.0020
514 IRRITABLE BOWEL SYNDROME 43 0.0020
515 HYPOTHYROIDISM 64 0.0020
516 HAEMORRHOIDS 39 0.0020
517 LABORATORY TEST ABNORMAL 59 0.0020
518 DRUG INTERACTION 317 0.0020
519 SURGERY 117 0.0020
520 WEIGHT DECREASED 557 0.0020
521 CONSTIPATION 433 0.0020
522 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
523 FATIGUE 1541 0.0020
524 ORAL CANDIDIASIS 26 0.0020
525 PRODUCT DISPENSING ERROR 43 0.0020
526 TUBULOINTERSTITIAL NEPHRITIS 37 0.0020
527 TREATMENT NONCOMPLIANCE 108 0.0020
528 WEIGHT INCREASED 442 0.0020
529 IMMUNE SYSTEM DISORDER 26 0.0020
530 DISORIENTATION 78 0.0020
531 NO THERAPEUTIC RESPONSE 24 0.0020
532 HEART RATE DECREASED 69 0.0020
533 SLUGGISHNESS 20 0.0020
534 SKIN HAEMORRHAGE 29 0.0020
535 IRON DEFICIENCY ANAEMIA 18 0.0019
536 DRUG EFFECT DECREASED 105 0.0019
537 BLOOD URINE PRESENT 37 0.0019
538 PRODUCT USE IN UNAPPROVED INDICATION 481 0.0019
539 THERAPY CHANGE 19 0.0019
540 MENTAL DISORDER 84 0.0019
541 COLD SWEAT 34 0.0019
542 POST PROCEDURAL COMPLICATION 37 0.0019
543 VENTRICULAR EXTRASYSTOLES 20 0.0019
544 NEUROPATHY PERIPHERAL 183 0.0019
545 HEAD DISCOMFORT 34 0.0019
546 INJECTION SITE MASS 71 0.0019
547 ABNORMAL DREAMS 53 0.0019
548 TENDERNESS 20 0.0019
549 WRIST FRACTURE 23 0.0019
550 TACHYPNOEA 26 0.0019
551 BLOOD PRESSURE ABNORMAL 38 0.0019
552 UPPER LIMB FRACTURE 38 0.0019
553 INCORRECT PRODUCT STORAGE 25 0.0019
554 TYPE 2 DIABETES MELLITUS 64 0.0019
555 INTERNATIONAL NORMALISED RATIO INCREASED 54 0.0019
556 FIBROMYALGIA 46 0.0019
557 BRONCHITIS 140 0.0019
558 ARTHROPATHY 105 0.0019
559 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
560 COGNITIVE DISORDER 88 0.0019
561 HYPERKALAEMIA 66 0.0019
562 VENTRICULAR TACHYCARDIA 31 0.0019
563 MALNUTRITION 21 0.0019
564 DIABETES MELLITUS 143 0.0019
565 DISABILITY 37 0.0019
566 BREAST CANCER METASTATIC 20 0.0019
567 HERNIA 36 0.0019
568 LIVER FUNCTION TEST ABNORMAL 54 0.0019
569 DIZZINESS POSTURAL 18 0.0019
570 EUPHORIC MOOD 19 0.0019
571 HIATUS HERNIA 24 0.0019
572 DYSURIA 68 0.0018
573 ABNORMAL BEHAVIOUR 73 0.0018
574 BLOOD GLUCOSE ABNORMAL 34 0.0018
575 NASAL CONGESTION 108 0.0018
576 PSYCHOTIC DISORDER 54 0.0018
577 DERMATITIS ALLERGIC 23 0.0018
578 AGITATION 134 0.0018
579 THROMBOCYTOPENIA 204 0.0018
580 BONE MARROW FAILURE 37 0.0018
581 BLADDER DISORDER 18 0.0018
582 IMPAIRED QUALITY OF LIFE 26 0.0018
583 AGEUSIA 45 0.0018
584 COAGULOPATHY 30 0.0018
585 HEART RATE INCREASED 178 0.0018
586 MUSCLE SPASMS 329 0.0018
587 EPISTAXIS 134 0.0018
588 DRUG DOSE OMISSION BY DEVICE 140 0.0018
589 WITHDRAWAL SYNDROME 75 0.0018
590 JAUNDICE 48 0.0018
591 BURNING SENSATION 125 0.0018
592 ORTHOSTATIC HYPOTENSION 31 0.0018
593 BLOOD TEST ABNORMAL 25 0.0018
594 ABDOMINAL DISTENSION 185 0.0018
595 INFLUENZA 197 0.0018
596 SWELLING 165 0.0018
597 PRODUCT USE ISSUE 331 0.0018
598 PERIPHERAL SWELLING 271 0.0018
599 ERUCTATION 34 0.0018
600 STEVENS-JOHNSON SYNDROME 39 0.0018
601 LYMPHADENOPATHY 62 0.0017
602 DEVICE MALFUNCTION 123 0.0017
603 ARTHRALGIA 727 0.0017
604 PRODUCTIVE COUGH 83 0.0017
605 SYNCOPE 173 0.0017
606 EAR INFECTION 46 0.0017
607 INCREASED APPETITE 33 0.0017
608 GASTROINTESTINAL PAIN 19 0.0017
609 DYSARTHRIA 65 0.0017
610 HYPOMAGNESAEMIA 24 0.0017
611 WOUND 48 0.0017
612 JOINT STIFFNESS 45 0.0017
613 PRODUCT DOSE OMISSION ISSUE 504 0.0017
614 RENAL FAILURE ACUTE 72 0.0017
615 DIVERTICULITIS 47 0.0017
616 DIPLOPIA 44 0.0017
617 DRUG LEVEL INCREASED 28 0.0017
618 FLUID RETENTION 86 0.0017
619 THERAPY NON-RESPONDER 76 0.0017
620 MUSCULOSKELETAL PAIN 88 0.0017
621 JOINT SWELLING 202 0.0017
622 EJECTION FRACTION DECREASED 26 0.0017
623 RESTLESSNESS 61 0.0017
624 EYE SWELLING 62 0.0017
625 DRUG INEFFECTIVE 2193 0.0017
626 BONE LOSS 25 0.0017
627 SEPSIS 185 0.0017
628 EXPIRED PRODUCT ADMINISTERED 55 0.0017
629 RENAL DISORDER 77 0.0017
630 PRODUCT PRESCRIBING ISSUE 36 0.0017
631 PULMONARY OEDEMA 74 0.0017
632 ABDOMINAL PAIN 384 0.0016
633 CHEST DISCOMFORT 169 0.0016
634 OESOPHAGITIS 18 0.0016
635 ARRHYTHMIA 78 0.0016
636 HYPERGLYCAEMIA 60 0.0016
637 PANCREATITIS ACUTE 37 0.0016
638 DYSPNOEA EXERTIONAL 62 0.0016
639 INTRAOCULAR PRESSURE INCREASED 21 0.0016
640 ACUTE RESPIRATORY DISTRESS SYNDROME 29 0.0016
641 PAIN IN EXTREMITY 483 0.0016
642 RESPIRATORY TRACT CONGESTION 26 0.0016
643 INJECTION SITE NODULE 18 0.0016
644 ACNE 124 0.0016
645 SKIN REACTION 23 0.0016
646 BLOOD CREATINE PHOSPHOKINASE INCREASED 47 0.0016
647 LUNG DISORDER 80 0.0016
648 THROAT TIGHTNESS 44 0.0016
649 BLOOD PRESSURE FLUCTUATION 39 0.0016
650 SKIN ULCER 42 0.0016
651 GLYCOSYLATED HAEMOGLOBIN INCREASED 41 0.0016
652 RASH PRURITIC 88 0.0016
653 ANAEMIA 309 0.0016
654 SENSORY DISTURBANCE 26 0.0016
655 GAIT DISTURBANCE 310 0.0016
656 ABNORMAL WEIGHT GAIN 20 0.0016
657 RESPIRATORY FAILURE 118 0.0016
658 ACTIVITIES OF DAILY LIVING IMPAIRED 32 0.0016
659 INTENTIONAL DOSE OMISSION 46 0.0016
660 DELUSION 25 0.0016
661 RHINORRHOEA 104 0.0016
662 TOOTH EXTRACTION 20 0.0016
663 DISCOMFORT 98 0.0016
664 HAEMATURIA 55 0.0016
665 THROAT IRRITATION 72 0.0016
666 DEVICE MECHANICAL ISSUE 22 0.0016
667 OEDEMA 87 0.0016
668 ACUTE MYELOID LEUKAEMIA 25 0.0016
669 NERVOUS SYSTEM DISORDER 50 0.0016
670 ARTHRITIS 126 0.0016
671 PARAESTHESIA 252 0.0016
672 HYPOAESTHESIA 239 0.0016
673 MEMORY IMPAIRMENT 219 0.0016
674 MYOCLONUS 19 0.0016
675 BLOOD BILIRUBIN INCREASED 43 0.0016
676 TOOTH LOSS 33 0.0016
677 MULTIPLE ORGAN DYSFUNCTION SYNDROME 45 0.0016
678 SKIN FISSURES 31 0.0016
679 MULTIPLE FRACTURES 26 0.0016
680 EYE PAIN 89 0.0016
681 TACHYCARDIA 140 0.0016
682 DERMATITIS 33 0.0016
683 NERVOUSNESS 82 0.0016
684 SOMNOLENCE 316 0.0016
685 DYSPEPSIA 154 0.0016
686 ALANINE AMINOTRANSFERASE INCREASED 96 0.0016
687 LOWER LIMB FRACTURE 30 0.0016
688 NIGHTMARE 54 0.0016
689 TREMOR 259 0.0016
690 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 111 0.0016
691 BLINDNESS UNILATERAL 22 0.0016
692 CARDIAC FAILURE 125 0.0016
693 PALPITATIONS 182 0.0016
694 URINARY INCONTINENCE 46 0.0016
695 HAEMOPTYSIS 43 0.0015
696 FALL 513 0.0015
697 CRYING 56 0.0015
698 MUSCULAR WEAKNESS 175 0.0015
699 BLOOD SODIUM DECREASED 29 0.0015
700 ILEUS 19 0.0015
701 DRY MOUTH 124 0.0015
702 HEPATOTOXICITY 34 0.0015
703 HAIR COLOUR CHANGES 19 0.0015
704 NEOPLASM PROGRESSION 53 0.0015
705 ORAL PAIN 34 0.0015
706 ANKYLOSING SPONDYLITIS 20 0.0015
707 DEHYDRATION 202 0.0015
708 DIZZINESS 754 0.0015
709 GENERALISED TONIC-CLONIC SEIZURE 25 0.0015
710 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 306 0.0015
711 LOSS OF CONSCIOUSNESS 193 0.0015
712 SKIN DISORDER 50 0.0015
713 URINARY RETENTION 50 0.0015
714 PNEUMONIA 485 0.0015
715 DISEASE RECURRENCE 71 0.0015
716 LIMB DISCOMFORT 46 0.0015
717 SKIN CANCER 32 0.0015
718 PELVIC PAIN 27 0.0015
719 HAEMATOCHEZIA 82 0.0015
720 ILLNESS 153 0.0015
721 MUSCLE TIGHTNESS 24 0.0015
722 CEREBRAL HAEMORRHAGE 53 0.0015
723 SINUS CONGESTION 20 0.0015
724 PSORIATIC ARTHROPATHY 60 0.0015
725 PROCEDURAL PAIN 41 0.0015
726 INCORRECT DOSE ADMINISTERED 337 0.0015
727 HEMIPARESIS 25 0.0015
728 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 77 0.0015
729 THERAPY PARTIAL RESPONDER 23 0.0015
730 VIRAL INFECTION 49 0.0015
731 KNEE ARTHROPLASTY 31 0.0015
732 HAEMORRHAGE INTRACRANIAL 22 0.0015
733 RESPIRATORY DISORDER 44 0.0015
734 BODY TEMPERATURE INCREASED 30 0.0015
735 HALLUCINATION, VISUAL 31 0.0015
736 PARALYSIS 21 0.0015
737 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
738 ENCEPHALOPATHY 36 0.0015
739 NAUSEA 1155 0.0015
740 SEROTONIN SYNDROME 28 0.0015
741 THIRST 26 0.0015
742 DYSGEUSIA 108 0.0015
743 INFLAMMATION 75 0.0015
744 FEELING HOT 89 0.0015
745 CONDITION AGGRAVATED 440 0.0014
746 FLATULENCE 82 0.0014
747 PROSTATE CANCER 116 0.0014
748 GASTROENTERITIS VIRAL 26 0.0014
749 EPILEPSY 44 0.0014
750 OSTEOMYELITIS 26 0.0014
751 INJECTION SITE SWELLING 110 0.0014
752 PHOTOPHOBIA 27 0.0014
753 AMENORRHOEA 25 0.0014
754 INFLUENZA LIKE ILLNESS 117 0.0014
755 GASTRIC ULCER 27 0.0014
756 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
757 HAIR TEXTURE ABNORMAL 19 0.0014
758 RENAL INJURY 42 0.0014
759 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
760 ACCIDENTAL EXPOSURE TO PRODUCT 145 0.0014
761 DEVICE BREAKAGE 57 0.0014
762 RASH MACULAR 49 0.0014
763 FEELING COLD 39 0.0014
764 GALLBLADDER DISORDER 25 0.0014
765 SPINAL FRACTURE 28 0.0014
766 BLOOD POTASSIUM DECREASED 42 0.0014
767 TRANSAMINASES INCREASED 31 0.0014
768 BACTERIAL INFECTION 26 0.0014
769 MOBILITY DECREASED 100 0.0014
770 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99 0.0014
771 COVID-19 244 0.0014
772 FULL BLOOD COUNT DECREASED 28 0.0014
773 PSYCHOMOTOR HYPERACTIVITY 23 0.0014
774 HALLUCINATION, AUDITORY 22 0.0014
775 FAECES DISCOLOURED 30 0.0014
776 COUGH 388 0.0014
777 SNEEZING 31 0.0014
778 CHILLS 162 0.0014
779 SCIATICA 22 0.0014
780 BLISTER 77 0.0014
781 MUSCULOSKELETAL DISORDER 26 0.0014
782 HYPOKALAEMIA 63 0.0014
783 PLEURAL EFFUSION 83 0.0014
784 HYPOXIA 48 0.0014
785 METABOLIC ACIDOSIS 43 0.0013
786 RESPIRATORY TRACT INFECTION 35 0.0013
787 BREAST CANCER 125 0.0013
788 DYSPNOEA 759 0.0013
789 PERICARDIAL EFFUSION 31 0.0013
790 HERPES ZOSTER 77 0.0013
791 DYSSTASIA 39 0.0013
792 GASTROINTESTINAL HAEMORRHAGE 111 0.0013
793 VISION BLURRED 182 0.0013
794 APHASIA 40 0.0013
795 CONFUSIONAL STATE 213 0.0013
796 RETCHING 28 0.0013
797 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 236 0.0013
798 HYPOKINESIA 19 0.0013
799 DRUG DISPENSING ERROR 20 0.0013
800 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
801 MALAISE 573 0.0013
802 GASTROENTERITIS 19 0.0013
803 DEAFNESS 34 0.0013
804 DIABETES MELLITUS INADEQUATE CONTROL 23 0.0013
805 HYPOGLYCAEMIA 63 0.0013
806 LYMPHOMA 20 0.0013
807 HEPATIC FAILURE 39 0.0013
808 CATARACT 77 0.0013
809 HUNGER 18 0.0013
810 INFECTION 187 0.0013
811 DECREASED APPETITE 300 0.0013
812 DEVICE DISLOCATION 56 0.0013
813 UNDERDOSE 94 0.0013
814 EAR PAIN 25 0.0013
815 ASPARTATE AMINOTRANSFERASE INCREASED 68 0.0013
816 BLINDNESS 52 0.0013
817 VISUAL IMPAIRMENT 158 0.0013
818 EXPOSURE VIA SKIN CONTACT 33 0.0013
819 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
820 ABDOMINAL DISCOMFORT 213 0.0013
821 MUSCULOSKELETAL STIFFNESS 111 0.0013
822 THERAPY CESSATION 65 0.0013
823 SKIN DISCOLOURATION 58 0.0013
824 TOOTH DISORDER 28 0.0013
825 LIVER FUNCTION TEST INCREASED 27 0.0013
826 ULCER 20 0.0013
827 CYSTITIS 40 0.0013
828 INJECTION SITE PAIN 385 0.0013
829 PERICARDITIS 21 0.0012
830 DEVICE FAILURE 19 0.0012
831 DEVICE LEAKAGE 54 0.0012
832 DYSPHAGIA 117 0.0012
833 SEIZURE 142 0.0012
834 PRODUCT DOSE OMISSION 80 0.0012
835 OCULAR HYPERAEMIA 58 0.0012
836 FREQUENT BOWEL MOVEMENTS 33 0.0012
837 SPEECH DISORDER 64 0.0012
838 VERTIGO 74 0.0012
839 HEPATITIS 31 0.0012
840 DRY EYE 60 0.0012
841 INJECTION SITE HAEMORRHAGE 96 0.0012
842 DIARRHOEA 774 0.0012
843 PNEUMOTHORAX 19 0.0012
844 CHOLESTASIS 23 0.0012
845 HAEMORRHAGE 125 0.0012
846 PHARMACEUTICAL PRODUCT COMPLAINT 31 0.0012
847 OXYGEN SATURATION DECREASED 67 0.0012
848 PYREXIA 411 0.0012
849 FEEDING DISORDER 24 0.0012
850 EYE IRRITATION 68 0.0012
851 WHEEZING 70 0.0012
852 PRURITUS 453 0.0012
853 ABDOMINAL PAIN UPPER 242 0.0012
854 BLOOD PRESSURE DECREASED 78 0.0012
855 HYPOPHAGIA 30 0.0012
856 KIDNEY INFECTION 23 0.0012
857 OSTEONECROSIS OF JAW 29 0.0012
858 BLOOD POTASSIUM INCREASED 19 0.0012
859 MEDICATION ERROR 65 0.0012
860 BLOOD GLUCOSE DECREASED 56 0.0012
861 UNRESPONSIVE TO STIMULI 30 0.0012
862 PNEUMONIA ASPIRATION 29 0.0012
863 GENERAL PHYSICAL HEALTH DETERIORATION 134 0.0012
864 VAGINAL HAEMORRHAGE 50 0.0012
865 ABDOMINAL PAIN LOWER 29 0.0011
866 LOCAL SWELLING 20 0.0011
867 OROPHARYNGEAL PAIN 106 0.0011
868 WHITE BLOOD CELL COUNT DECREASED 124 0.0011
869 DEVICE USE ISSUE 20 0.0011
870 FUNGAL INFECTION 38 0.0011
871 RASH 490 0.0011
872 ASCITES 33 0.0011
873 PRODUCT PREPARATION ERROR 23 0.0011
874 DRUG WITHDRAWAL SYNDROME 98 0.0011
875 RASH PAPULAR 25 0.0011
876 HALLUCINATION 84 0.0011
877 INTESTINAL OBSTRUCTION 42 0.0011
878 SEDATION 29 0.0011
879 DRUG DOSE OMISSION 183 0.0011
880 ALOPECIA 217 0.0011
881 DEVICE ISSUE 99 0.0011
882 VOMITING 518 0.0011
883 HYPOTENSION 221 0.0011
884 PULMONARY FIBROSIS 21 0.0011
885 ERYTHEMA 224 0.0011
886 ANAPHYLACTIC REACTION 60 0.0011
887 RASH GENERALISED 28 0.0011
888 URTICARIA 181 0.0011
889 CONJUNCTIVITIS 20 0.0011
890 CARDIO-RESPIRATORY ARREST 45 0.0011
891 BRADYCARDIA 57 0.0011
892 ASTHMA 121 0.0011
893 ILL-DEFINED DISORDER 65 0.0011
894 INJECTION SITE BRUISING 85 0.0011
895 HAEMATEMESIS 27 0.0011
896 BLOOD GLUCOSE INCREASED 200 0.0011
897 GASTROINTESTINAL DISORDER 95 0.0011
898 INJECTION SITE URTICARIA 26 0.0011
899 ADVERSE DRUG REACTION 95 0.0011
900 RESPIRATORY DISTRESS 29 0.0010
901 DRUG EFFECT INCOMPLETE 38 0.0010
902 URINARY TRACT INFECTION 178 0.0010
903 DRUG PRESCRIBING ERROR 20 0.0010
904 FEMUR FRACTURE 32 0.0010
905 THERAPEUTIC RESPONSE SHORTENED 34 0.0010
906 ORAL HERPES 20 0.0010
907 VISUAL ACUITY REDUCED 34 0.0010
908 NASOPHARYNGITIS 188 0.0010
909 INCORRECT PRODUCT ADMINISTRATION DURATION 22 0.0010
910 NEUTROPENIA 138 0.0010
911 SKIN IRRITATION 46 0.0010
912 RASH ERYTHEMATOUS 48 0.0010
913 LIVER DISORDER 44 0.0010
914 HEPATIC FUNCTION ABNORMAL 37 0.0010
915 CONTRAINDICATED PRODUCT ADMINISTERED 30 0.0010
916 GLAUCOMA 19 0.0010
917 TASTE DISORDER 20 0.0010
918 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 46 0.0010
919 COLITIS ULCERATIVE 44 0.0010
920 EYE PRURITUS 33 0.0010
921 MOVEMENT DISORDER 31 0.0010
922 WRONG TECHNIQUE IN DRUG USAGE PROCESS 35 0.0010
923 HEPATIC CIRRHOSIS 18 0.0010
924 MOUTH ULCERATION 20 0.0009
925 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
926 GLOSSODYNIA 21 0.0009
927 ECZEMA 49 0.0009
928 DRUG RESISTANCE 24 0.0009
929 PSORIASIS 122 0.0009
930 HIP FRACTURE 30 0.0009
931 ABASIA 23 0.0009
932 SUICIDE ATTEMPT 56 0.0009
933 DERMATITIS ATOPIC 48 0.0009
934 DRY SKIN 120 0.0009
935 PANCYTOPENIA 50 0.0009
936 INTENTIONAL SELF-INJURY 18 0.0009
937 SKIN EXFOLIATION 75 0.0009
938 EYE DISORDER 29 0.0009
939 PNEUMONITIS 24 0.0009
940 GAIT INABILITY 29 0.0009
941 THERAPY INTERRUPTED 62 0.0009
942 RECTAL HAEMORRHAGE 37 0.0009
943 INTENTIONAL DRUG MISUSE 18 0.0009
944 NEUTROPHIL COUNT DECREASED 35 0.0009
945 STOMATITIS 52 0.0009
946 INJECTION SITE PRURITUS 57 0.0009
947 DYSKINESIA 34 0.0008
948 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
949 SEPTIC SHOCK 36 0.0008
950 CONVULSION 47 0.0008
951 COLITIS 31 0.0008
952 GASTRIC DISORDER 28 0.0008
953 INJECTION SITE ERYTHEMA 100 0.0008
954 TREATMENT FAILURE 66 0.0008
955 ADVERSE EVENT 73 0.0008
956 INJECTION SITE REACTION 54 0.0008
957 DELIRIUM 27 0.0008
958 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
959 DISEASE PROGRESSION 90 0.0008
960 COMA 36 0.0008
961 DEMENTIA 21 0.0008
962 COMPLETED SUICIDE 62 0.0007
963 HYPOACUSIS 32 0.0007
964 PAIN OF SKIN 20 0.0007
965 EXTRA DOSE ADMINISTERED 30 0.0007
966 ACCIDENTAL OVERDOSE 27 0.0007
967 DEPRESSED LEVEL OF CONSCIOUSNESS 29 0.0007
968 NEOPLASM MALIGNANT 48 0.0007
969 DEATH 580 0.0007
970 HOSPITALISATION 103 0.0007
971 LUNG NEOPLASM MALIGNANT 27 0.0007
972 INJECTION SITE RASH 20 0.0007
973 PLASMA CELL MYELOMA 25 0.0006
974 LIP SWELLING 21 0.0006
975 MULTIPLE SCLEROSIS 29 0.0006
976 DEVICE USE ERROR 21 0.0006
977 OVERDOSE 130 0.0006
978 INTENTIONAL OVERDOSE 38 0.0006
979 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
980 FEBRILE NEUTROPENIA 37 0.0006
981 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
982 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
983 C-REACTIVE PROTEIN INCREASED 19 0.0005
984 SKIN BURNING SENSATION 37 0.0005
985 RHEUMATOID ARTHRITIS 58 0.0005
986 MULTIPLE SCLEROSIS RELAPSE 34 0.0005
987 TOXICITY TO VARIOUS AGENTS 81 0.0005
988 INTERSTITIAL LUNG DISEASE 23 0.0005
989 LEUKOPENIA 23 0.0005
990 DEVICE EXPULSION 26 0.0004
991 DRUG DEPENDENCE 55 0.0003
992 BLADDER CANCER 20 0.0003
993 DEVICE DIFFICULT TO USE 21 0.0003